Xenofon Baraliakos
Overview
Explore the profile of Xenofon Baraliakos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
393
Citations
7503
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Steimer A, Gotschi A, Witte T, Scherer A, Brandli J, Nissen M, et al.
Clin Rheumatol
. 2025 Mar;
PMID: 40063233
Objectives: Anti-CD74 antibodies (Abs) have been proposed as a diagnostic biomarker in axial spondyloarthritis (axSpA). The aims of this study were to evaluate the association of these Abs with disease...
2.
Nash P, Kerschbaumer A, Konzett V, Aletaha D, Dorner T, Fleischmann R, et al.
Ann Rheum Dis
. 2025 Mar;
PMID: 40037995
In light of the introduction of new Janus kinase inhibitors (JAKi), new indications for JAKi and recent safety considerations that have arisen since the preceding consensus statement on JAKi therapy,...
3.
Kiefer D, Braun J, Kiltz U, Kolle N, Schneider L, Andreica I, et al.
Joint Bone Spine
. 2025 Feb;
:105873.
PMID: 40015364
Objective: To investigate prevalence and associations of kinesiophobia on patients with axSpA, and its relation to global functioning and health, disease activity, function, spinal mobility and physical activity in comparison...
4.
Pfeil A, Fleck M, Aringer M, Baraliakos X, Ernst D, Haase I, et al.
Z Rheumatol
. 2025 Feb;
PMID: 40014094
The model advanced training regulations define the content of advanced training to achieve the qualification of medical specialist in all specialties and sub-specialties of medicine. As rheumatology is one of...
5.
Poddubnyy D, Navarro-Compan V, Torgutalp M, Arends S, Aydin S, Battista S, et al.
Ann Rheum Dis
. 2025 Feb;
PMID: 39955166
Objectives: To develop a consensus-based expert definition of difficult-to-manage (D2M) axial spondyloarthritis (axSpA), incorporating treatment-refractory (TR) disease. Methods: A literature review was conducted in 2022 to identify potential definitions for...
6.
van der Heijde D, Navarro-Compan V, Landewe R, Sieper J, van Gaalen F, Gensler L, et al.
Ann Rheum Dis
. 2025 Feb;
84(3):382-387.
PMID: 39948004
Objective: To describe the role of the Assessment of SpondyloArthritis interntational Society (ASAS) over the past 30 years in the understanding of the field of spondyloarthritis. Methods: A narrative review...
7.
Konzett V, Smolen J, Nash P, Aletaha D, Winthrop K, Dorner T, et al.
Ann Rheum Dis
. 2025 Feb;
PMID: 39934019
Objective: This systematic literature review (SLR) on efficacy outcomes was performed to inform the 2024 update of the expert consensus statement on the treatment of immune-mediated inflammatory diseases (IMIDs) with...
8.
Konzett V, Smolen J, Nash P, Winthrop K, Aletaha D, Dorner T, et al.
Ann Rheum Dis
. 2025 Feb;
PMID: 39934016
Objectives: This systematic literature review (SLR) on safety outcomes was performed to inform the 2024 update of the expert consensus statement on the treatment of immune-mediated inflammatory diseases (IMIDs) with...
9.
Van den Bosch F, Deodhar A, Poddubnyy D, Maksymowych W, van der Heijde D, Kim T, et al.
Arthritis Res Ther
. 2025 Feb;
27(1):23.
PMID: 39905436
Background: In SELECT-AXIS 2, upadacitinib improved the signs and symptoms of active non-radiographic axial spondyloarthritis (nr-axSpA) through 52 weeks versus placebo and was well tolerated. Here, we evaluated the efficacy...
10.
Weber U, Seven S, Pedersen S, Ostergaard M, Machado P, Wichuk S, et al.
J Rheumatol
. 2025 Feb;
PMID: 39892890
Objective: To assess the effect of increasing age on the frequency of inflammatory and structural magnetic resonance imaging (MRI) lesions in the sacroiliac joints (SIJ) in 3 independent cohorts of...